Cargando…
Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
Body fluids often contain freely circulating nucleic acids, many of which can be exploited as noninvasive tools for the diagnosis of cancer as well as for clinical prognostication. Identifying microRNAs (miRNAs) in subjects' blood with various malignancies means that they can serve as novel bio...
Autores principales: | Jin, Wei, Fei, Xiang, Wang, Xia, Chen, Fangjie, Song, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230987/ https://www.ncbi.nlm.nih.gov/pubmed/32455140 http://dx.doi.org/10.1155/2020/5873056 |
Ejemplares similares
-
Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia
por: SANCER, Okan, et al.
Publicado: (2022) -
Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients
por: Haj-Ahmad, Taha A, et al.
Publicado: (2014) -
Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer
por: de Souza, Marilesia Ferreira, et al.
Publicado: (2017) -
Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy
por: Kachris, Stefanos, et al.
Publicado: (2021) -
miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia
por: Liu, Liya, et al.
Publicado: (2015)